| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Published online before print January 15, 2009
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






From the Department of Neuropathology,* Charité Universitätsmedizin, Berlin, Germany; the Institute of Immunology,
College of Veterinary Medicine, and the Molecular Pathogenesis Group,
Center for Biotechnology and Biomedicine, University of Leipzig, Leipzig, Germany; the Gerhard Domagk Institute for Pathology,
University of Münster, Münster, Germany; the Medical Research Council Laboratory of Molecular Biology,¶ Cambridge, United Kingdom; the Institute of Infectious Disease and Molecular Medicine and International Centre for Genetic Engineering and Biotechnology,|| University of Cape Town, Cape Town, South Africa
Both interleukin (IL)-4- and IL-13-dependent Th2-mediated immune mechanisms exacerbate murine Cryptococcus neoformans-induced bronchopulmonary disease. To study the roles of IL-4 and IL-13 in cerebral cryptococcosis, IL-4 receptor
-deficient (IL-4R
–/–), IL-4-deficient (IL-4–/–), IL-13-deficient (IL-13–/–), IL-13 transgenic (IL-13T/+), and wild-type mice were infected intranasally. IL-13T/+ mice displayed a higher fungal brain burden than wild-type mice, whereas the brain burdens of IL-4R
–/–, IL-4–/–, and IL-13–/– mice were significantly lower as compared with wild-type mice. On infection, 68% of wild-type mice and 88% of IL-13-overexpressing IL-13T/+ mice developed significant cerebral lesions. In contrast, only a few IL-4R
–/–, IL-4–/–, and IL-13–/– mice had small lesions in their brains. Furthermore, IL-13T/+ mice harbored large pseudocystic lesions in the central nervous system parenchyma, bordered by voluminous foamy alternatively activated macrophages (aaMphs) that contained intracellular cryptococci, without significant microglial activation. In wild-type mice, aaMphs tightly bordered pseudocystic lesions as well, and these mice, in addition, showed microglial cell activation. Interestingly, in resistant IL-4–/–, IL-13–/–, and IL-4R
–/– mice, no aaMphs were discernible. Microglial cells of all mouse genotypes neither internalized cryptococci nor expressed markers of alternative activation, although they displayed similar IL-4R
expression levels as macrophages. These data provide the first evidence of the development of aaMphs in a central nervous system infectious disease model, pointing to distinct roles of macrophages versus microglial cells in the central nervous system immune response against C. neoformans.
This article has been cited by other articles:
![]() |
K. S. Subramaniam, K. Datta, M. S. Marks, and L.-a. Pirofski Improved Survival of Mice Deficient in Secretory Immunoglobulin M following Systemic Infection with Cryptococcus neoformans Infect. Immun., January 1, 2010; 78(1): 441 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Jain, Y. Zhang, W. B. Fields, D. A. McNamara, M. Y. Choe, G.-h. Chen, J. Erb-Downward, J. J. Osterholzer, G. B. Toews, G. B. Huffnagle, et al. Th2 but Not Th1 Immune Bias Results in Altered Lung Functions in a Murine Model of Pulmonary Cryptococcus neoformans Infection Infect. Immun., December 1, 2009; 77(12): 5389 - 5399. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, F. Wang, K. C. Tompkins, A. McNamara, A. V. Jain, B. B. Moore, G. B. Toews, G. B. Huffnagle, and M. A. Olszewski Robust Th1 and Th17 Immunity Supports Pulmonary Clearance but Cannot Prevent Systemic Dissemination of Highly Virulent Cryptococcus neoformans H99 Am. J. Pathol., December 1, 2009; 175(6): 2489 - 2500. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |